Post Exercise Recovery and FST
Launched by UNIVERSITY OF BRITISH COLUMBIA · Jul 21, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how Fascial Stretch Therapy (FST) can help university athletes recover after exercise. The goal is to see if FST can make athletes feel less sore and tired after their workouts, which could improve their overall health and performance. A certified FST practitioner will guide the therapy, and after the sessions, athletes will fill out a questionnaire to share how they felt about their recovery.
To participate in this study, athletes must be UBCO students who are at least 19 years old and actively training. However, those who are under 19 or have a current injury or medical condition that affects their ability to train normally won't be able to join. This trial is not yet recruiting participants, but it aims to provide valuable insights into how FST might benefit athletes in their recovery process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Must be an UBCO student athlete who is at least 19 years of age and currently engaged in normal athletic training
- Exclusion Criteria:
- • Student athletes under 19 years of age or currently have an existing musculoskeletal injury or medical condition preventing you from engaging in normal athletic training.
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported